These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11278807

  • 1. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
    Keller JE, Neale EA.
    J Biol Chem; 2001 Apr 20; 276(16):13476-82. PubMed ID: 11278807
    [Abstract] [Full Text] [Related]

  • 2. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE, Cai F, Neale EA.
    Biochemistry; 2004 Jan 20; 43(2):526-32. PubMed ID: 14717608
    [Abstract] [Full Text] [Related]

  • 3. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
    Keller JE, Neale EA, Oyler G, Adler M.
    FEBS Lett; 1999 Jul 30; 456(1):137-42. PubMed ID: 10452545
    [Abstract] [Full Text] [Related]

  • 4. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival.
    Williamson LC, Neale EA.
    J Neurosci Res; 1998 Jun 01; 52(5):569-83. PubMed ID: 9632313
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
    Apland JP, Adler M, Oyler GA.
    J Protein Chem; 2003 Feb 01; 22(2):147-53. PubMed ID: 12760419
    [Abstract] [Full Text] [Related]

  • 6. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV, Yoshino K, Jahnz M, Dörries C, Bade S, Nauenburg S, Niemann H, Binz T.
    J Neurochem; 1999 Jan 01; 72(1):327-37. PubMed ID: 9886085
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA, Trimble WS, Charlton MP.
    Eur J Neurosci; 1998 Aug 01; 10(8):2617-28. PubMed ID: 9767392
    [Abstract] [Full Text] [Related]

  • 8. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa.
    Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA.
    J Biol Chem; 1996 Mar 29; 271(13):7694-9. PubMed ID: 8631808
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
    Lawrence GW, Ovsepian SV, Wang J, Aoki KR, Dolly JO.
    Neuropharmacology; 2013 Jul 29; 70():287-95. PubMed ID: 23485402
    [Abstract] [Full Text] [Related]

  • 10. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
    Lawrence GW, Foran P, Dolly JO.
    Eur J Biochem; 1996 Mar 15; 236(3):877-86. PubMed ID: 8665909
    [Abstract] [Full Text] [Related]

  • 11. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
    Lawrence GW, Wang J, Brin MF, Aoki KR, Wheeler L, Dolly JO.
    FEBS J; 2014 Jul 15; 281(14):3243-60. PubMed ID: 24863955
    [Abstract] [Full Text] [Related]

  • 12. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Südhof TC, Niemann H, Jahn R.
    Nature; 1993 Sep 09; 365(6442):160-3. PubMed ID: 8103915
    [Abstract] [Full Text] [Related]

  • 13. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
    Zhang P, Ray R, Singh BR, Ray P.
    Toxicon; 2013 Dec 15; 76():37-43. PubMed ID: 24047963
    [Abstract] [Full Text] [Related]

  • 14. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
    Lawrence GW, Foran P, Mohammed N, DasGupta BR, Dolly JO.
    Biochemistry; 1997 Mar 18; 36(11):3061-7. PubMed ID: 9115981
    [Abstract] [Full Text] [Related]

  • 15. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
    Adler M, Keller JE, Sheridan RE, Deshpande SS.
    Toxicon; 2001 Mar 18; 39(2-3):233-43. PubMed ID: 10978741
    [Abstract] [Full Text] [Related]

  • 16. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool.
    Stigliani S, Raiteri L, Fassio A, Bonanno G.
    J Neurochem; 2003 Apr 18; 85(2):409-21. PubMed ID: 12675917
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.
    Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO.
    J Biol Chem; 2003 Jan 10; 278(2):1363-71. PubMed ID: 12381720
    [Abstract] [Full Text] [Related]

  • 18. Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal.
    Neale EA, Bowers LM, Jia M, Bateman KE, Williamson LC.
    J Cell Biol; 1999 Dec 13; 147(6):1249-60. PubMed ID: 10601338
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
    Washbourne P, Pellizzari R, Baldini G, Wilson MC, Montecucco C.
    FEBS Lett; 1997 Nov 24; 418(1-2):1-5. PubMed ID: 9414082
    [Abstract] [Full Text] [Related]

  • 20. Long-distance retrograde effects of botulinum neurotoxin A.
    Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M.
    J Neurosci; 2008 Apr 02; 28(14):3689-96. PubMed ID: 18385327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.